Bifidobacterium Pseudocatenulatum-Derived Metabolite C16 Overcomes ICB Resistance by Targeting Integrin α9 Signaling and Remodeling Macrophage–T Cell Crosstalk
Published: 11 March 2026| Version 1 | DOI: 10.17632/jgp788dcdy.1
Contributor:
Zheng YashangDescription
RNAseq data of bone marrow-derived mouse macrophages treated with C16 and Vehicle
Files
Categories
Cancer, RNA